National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 5093 [2010-1932]
Download as PDF
jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices
Name of Committee: National Cancer
Institute Special Emphasis Panel, Innovative
Technologies Development.
Date: March 10–11, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Jeffrey E. DeClue, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 8059,
Bethesda, MD 20892–8329, 301–496–7904,
decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, EDRN
Biomarker Development Labs (U01).
Date: March 10–11, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Sherwood Githens, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Blvd. Room 8146, Bethesda, MD
20892, 301–435–1822,
githenss@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Development of Anticancer Agents.
Date: March 24–26, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Joyce C. Pegues, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, NIH National Cancer Institute,
6116 Executive Boulevard, Room 7149,
Bethesda, MD 20892–8329, 301–594–1286,
peguesj@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Nanotechnology Platform Partnerships.
Date: March 31–April 1, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Savvas C Makrides, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Rm 8053, Bethesda,
MD 20892, 301–496–7421,
makridessc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Small
Grants Program for Cancer Epidemiology.
Date: April 15–16, 2010.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Nov<24>2008
18:35 Jan 29, 2010
Jkt 220001
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Joyce C. Pegues, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 7149,
Bethesda, MD 20892–8329, 301–594–1286,
peguesj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 25, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
5093
Review, Group Neurological Sciences and
Disorders A.
Date: March 3, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Argonaut Hotel, 495 Jefferson Street,
San Francisco, CA 94109.
Contact Person: Richard D. Crosland, PhD,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS, Neuroscience Center,
6001 Executive Blvd., Suite 3208, MSC 9529,
Bethesda, MD 20892–9529, 301–496–9223.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
[FR Doc. 2010–2030 Filed 1–29–10; 8:45 am]
Dated: January 25, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
[FR Doc. 2010–1932 Filed 1–29–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders B.
Date: February 25–26, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: US Grant Hotel, 326 Broadway, San
Diego, CA 92101.
Contact Person: Ernest W Lyons, PhD,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3208,
MSC 9529, Bethesda, MD 20892–9529, 301–
496–4056.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Agency for Healthcare Research and
Quality
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as-needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularly
scheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b (c)(6). Grant
applications for the ARRA: Limited
Competition ‘‘Electronic Data Methods’’
(U13) applications are to be reviewed
and discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
E:\FR\FM\01FEN1.SGM
01FEN1
Agencies
[Federal Register Volume 75, Number 20 (Monday, February 1, 2010)]
[Notices]
[Page 5093]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-1932]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Initial Review Group, Neurological Sciences and Disorders
B.
Date: February 25-26, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: US Grant Hotel, 326 Broadway, San Diego, CA 92101.
Contact Person: Ernest W Lyons, PhD, Scientific Review Officer,
Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001
Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892-9529, 301-
496-4056.
Name of Committee: National Institute of Neurological Disorders
and Stroke Initial Review, Group Neurological Sciences and Disorders
A.
Date: March 3, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Argonaut Hotel, 495 Jefferson Street, San Francisco, CA
94109.
Contact Person: Richard D. Crosland, PhD, Scientific Review
Officer, Scientific Review Branch, Division of Extramural Research,
NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite
3208, MSC 9529, Bethesda, MD 20892-9529, 301-496-9223.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: January 25, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-1932 Filed 1-29-10; 8:45 am]
BILLING CODE 4140-01-P